ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaarVaxcyte Switzerland GmbH
Vaxcyte Switzerland GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Vaxcyte Switzerland GmbH is a vaccine development company focused on preventing bacterial infections such as pneumococcal disease, Group A Strep and Shigella. The company develops vaccine candidates and uses a cell-free protein synthesis platform to support the design and manufacture of complex vaccines.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Vaxcyte Switzerland GmbH

✓ Offered5
Pneumococcal Conjugate Vaccines
Pneumococcal conjugate vaccines for prevention of invasive pneumococcal disease, including VAX-31 and VAX-24 for adults and infants with broad serotype coverage.
Vaccine Research and Development Platform
Vaccine research and development platform using cell-free protein synthesis, advanced chemistry and site-specific conjugation to develop complex, broad-spectrum vaccines.
Group A Streptococcus Vaccines
Vaccine candidates against Group A Streptococcus, including VAX-A1, being developed for adults and in preclinical work for children.
Shigella Vaccines
Vaccine candidates against Shigella, including VAX-GI, for prevention of dysentery and shigellosis in preclinical development.
Collaboration and Partnership Opportunities
Collaboration and partnership opportunities to advance the vaccine platform and pipeline through strategic alliances and business development.
Trust & reputation

ranQ Trust Score of Vaxcyte Switzerland GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Vaxcyte Switzerland GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Vaxcyte Switzerland GmbH scores 61.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.50.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Vaxcyte Switzerland GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Vaxcyte Switzerland GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Vaxcyte Switzerland GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Vaxcyte Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Vaxcyte Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Vaxcyte Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Vaxcyte Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Haldenstrasse 5
6340 Baar

At a glance

Legal form
Limited Liability Company
UID
CHE-175.563.693
Founded
2023 · 3 years
Last commercial register change
September 11, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    GA
    GlaxoSmithKline AG Zweigniederlassung Baar/Zug
    Baar
    GA
    GlaxoSmithKline AG
    Baar
    AA
    AstraZeneca AG
    Baar
    EA
    Extrovis AG
    Baar
    TO
    Taiho Oncology Europe GmbH
    Baar
    PB
    Panacea Biotec (International) SA
    Zug
    WB
    Wockhardt Bio AG
    Zug
    SI
    Sanofi International AG
    Rotkreuz